The groundbreaking therapy of this peptide represents a significant development in the management of type 2 diabetes. Different to existing medications, tirzepatide targets dual pathways – GLP-1 and GIP – resulting https://tirzepatidepeptide082913.blue-blogs.com/50278102/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment